, Directive (EU) 1993/41

In forcesince 14 Jun 1993

Whereas provision has been made in Directive 93/39/EEC [See page 22 of this Official Journal.] for the continued management of marketing authorizations which have been granted by Member States following the opinion of the Committee for Proprietary Medicinal Products given in accordance with Directive 87/22/EEC;

  • celex=31987L0022
  • celex=31993L0039